We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PPT:ASXPerpetual Limited Analysis

Data as of 2026-05-25 - not real-time

A$16.12

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Perpetual Limited is trading at $16.12, below its 20‑day SMA of 16.37 and 50‑day SMA of 16.24, indicating short‑term weakness, while the 200‑day SMA sits at 18.39, suggesting a longer‑term downtrend. The RSI of 46.7 is neutral, but the MACD histogram is negative and the signal line is labeled bearish, reinforcing modest downside pressure. Volume is decreasing, and the price sits near the computed support of 15.69 with resistance around 16.88, framing a tight trading range. Market sentiment is at an Extreme Greed level (91.61 on the Fear & Greed Index), which may be inflating short‑term buying interest despite the technical softness. On the fundamentals side, the stock appears significantly undervalued: the DCF fair value is $25.36 versus the current price, implying a potential upside of 21%. The forward PE of 10.08 is well below the industry average of 16.75, and the forward EPS of 1.60 points to earnings recovery. However, the company posted a negative trailing EPS (-0.16) and a profit margin of -1.16%, with a high payout ratio of 219%, raising concerns about dividend sustainability. Debt levels are elevated (debt‑to‑equity of 56.4%) and the max drawdown of 28.6% reflects historical volatility. The beta of 0.75 and 30‑day volatility of 23% suggest moderate market sensitivity but higher price swings. Overall, the stock offers a compelling valuation gap but is tempered by earnings weakness, leverage, and an unsustainable dividend policy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and decreasing volume
  • Support level near current price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of ~21% and forward PE advantage
  • Improving forward EPS expectations
  • Extreme greed sentiment may correct

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to fair value
  • Stable dividend yield despite sustainability concerns
  • Moderate beta and sector positioning in asset management

Key Metrics & Analysis

Financial Health

Revenue Growth1.60%
Profit Margin-1.16%
P/E Ratio10.1
ROE-0.96%
ROA3.48%
Debt/Equity56.41
P/B Ratio1.1
Op. Cash FlowA$253.2M
Free Cash FlowA$252.1M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI46.7
SupportA$15.69
ResistanceA$16.88
MA 20A$16.37
MA 50A$16.24
MA 200A$18.39
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair ValueA$25.36
Target PriceA$19.51
Upside/Downside21.01%
GradeUndervalued
TypeValue
Dividend Yield6.95%

Risk Assessment

Beta0.75
Volatility23.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.